Nabanita De, PhD

Associate Director at City Therapeutics

Speaker

Nabanita De is an Associate Director at City Therapeutics, where she leads the development of novel RNAi triggers. She has nearly a decade of experience in drug development, with a strong track record in advancing innovative modalities such as RNAi, mRNA, and targeted small molecule degraders. Before joining City Therapeutics, Dr. De served as an Associate Director at Arrakis Therapeutics, where she led platform development for targeted small molecule degraders of mRNA. Prior to that, she spent four years at GreenLight Biosciences, contributing across multiple research initiatives spanning RNAi platform enablement to mRNA platform development. Dr. De earned her M.Sc. in Chemistry from Indian Institute of Technology, Ph.D. in Chemistry and Chemical Biology from Cornell University and completed her postdoctoral research at The Scripps Research Institute and at Harvard Medical School/Massachusetts General Hospital.